Dow closes lower Wednesday, notching third straight losing session as bond yields rise: Live updates
The three major averages slid as Treasury yields climbed higher.
‘A trove of rebound opportunities’: Strategists turn bullish on biotech and more, picking top stocks
2023 wasn’t a good year for the health-care sector, but some investors expect it to rebound this year — highlighting biotech and medical tech as areas to watch.
‘Buy on the dips’: Morgan Stanley names its favorite stocks in European tech
Europe’s technology hardware sector’s “roller coaster year” of 2023 ended on a strong note, and a cyclical recovery is underway, according to the bank.
Top pharma CEO says preparedness for a new pandemic has not improved
Vas Narasimhan, CEO of Novartis, told CNBC that he didn’t believe there had been much improvement in preparedness for pandemics.
The top 9 ‘must-have’ travel experiences of 2024, according to luxury advisors
The luxury travel company Virtuoso asked 20,000 travel advisors to share the experiences that should top travelers’ lists in 2024.
Red Sea risk to oil ‘very real,’ prices could change rapidly if supply disrupted, Chevron CEO says
“It’s a very serious situation and seems to be getting worse,” Chevron CEO Michael Wirth said of the crisis in the Red Sea.
Finding quality stocks in what could be a tougher year for investors
These are some quality names worth considering if the market proves to be more turbulent.
China’s Taiwan approach ‘has been counterproductive,’ Blinken says
Blinken spoke on China relations following the Taiwan elections at the World Economic Forum in Davos.
SEC says ‘no evidence’ unauthorized party who posted to X accessed agency systems: CNBC Crypto World
CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry….
UBS raises S&P 500 target for 2024, sees nearly 8% gain from here
This year’s more dovish Federal Reserve policy supports higher valuations and above-trend EPS revisions, according to strategist Jonathan Golub.
